Navigation Links
Internal Fixation Systems, Inc. Receives FDA 510(k) Clearance to Market Fixation Devices to Treat Bone Fractures and Osteotomies
Date:9/14/2011

MIAMI, Sept. 14, 2011 /PRNewswire/ -- Internal Fixation Systems, Inc. (OTC QB: IFIX) today announces that it has received U.S. Food and Drug Administration (FDA) clearance to market its bone fixation devices that include various plates, screws, and washers used to treat bone fractures and osteotomies.

The 510(k) clearance authorizes IFS to market a line of locking plates which includes mini-fragment, small fragment, and large fragment systems.  The initial system, a modular locking small fragment set, should be available for sale during the 4th quarter 2011.

"The comprehensive family of locking plate products will allow us to compete in the rapidly growing US orthopedic fracture fixation market," says Ken West, Founder and Vice President of Sales.  "IFS's enhanced products and responsible pricing should position the company well in this competitive market."

"The locking small fragment system is the first step in the build-out of our complete line of orthopedic implants," according to Christopher D. Endara, Founder and Vice President of Engineering, Operations, Quality, and Regulatory Affairs.

"The approval of these devices will benefit patients and surgeons by providing high quality, cost effective alternatives critical in today's healthcare environment," said Internal Fixation Systems President and CEO, Stephen Dresnick, MD. Over the last 18 months, we have developed several new product lines and are developing the infrastructure to grow."

About IFS:  Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants.  We seek to prove that superior products and lower costs can go hand in hand.  IFS focuses on widely used, market proven products used to treat common fractures.  Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs.  The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition.  IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons.  Please contact us for more information about our product and business model.This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events.  Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as the statements that Internal Fixation anticipates the launch of the locking plate and screw systems   There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including whether Internal Fixation will have sufficient capital to continue its operations..  Actual results and future events could differ materially from those anticipated in such information.  These and all subsequent written and oral forward-looking information are based on estimates and views of  management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS does not intend to update these forward-looking statements.For further information, please contact:

Laura Cattabriga, Chief Financial OfficerTel: 786 268 0995Laura.cattabriga@ifsusa.net
'/>"/>

SOURCE Internal Fixation Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
2. Building Support for a New Product Through Effective Internal Disease State Communication
3. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
4. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
5. Maximizing the Potential of Internal and External Communications Groups
6. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
7. SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
8. Toriseva Law and Karon & Dalimonte LLP: Archives of Internal Medicine Article Faults Manufacturers of IVC Filters
9. Corporate Affairs Role in Internal and External Relationships Key to Organizational Success
10. International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network
11. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):